Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,030	2,504	1,331	7,103	367.81
Short-Term Investments	19.5	11.03	21.31	4.88	2.41
Trading Asset Securities	1,829	1,275	865.97	155.61	1,588
Cash & Short-Term Investments	5,878	3,790	2,218	7,263	1,959
Cash Growth	55.11%	70.85%	-69.46%	270.86%	137.40%
Accounts Receivable	141.28	102.03	69.42	65.64	54.52
Other Receivables	7.34	14.55	4.6	6.7	201.31
Receivables	148.62	116.57	74.02	72.34	255.83
Inventory	310.81	200.44	183.9	89.39	64.66
Other Current Assets	64.17	28.26	61.58	16.11	5.06
Total Current Assets	6,402	4,135	2,538	7,441	2,284
Property, Plant & Equipment	1,093	711.62	551.65	333.53	280.71
Other Intangible Assets	5.82	7.36	6.75	7.6	8.78
Long-Term Deferred Tax Assets	0.91	1.11	1.19	1.35	1.23
Other Long-Term Assets	536.49	117.91	40.9	94.41	76.28
Total Assets	8,038	4,973	3,138	7,878	2,651
Accounts Payable	286.71	133.11	54.65	23.61	31.95
Accrued Expenses	61.36	40.72	28.5	28.93	40.51
Current Portion of Leases	4.7	1.56	0.88	-	-
Current Income Taxes Payable	117.02	116.72	75.02	71.36	144.23
Current Unearned Revenue	18.68	37.25	13.95	17.78	3.85
Other Current Liabilities	347.53	201.25	107.9	6,701	1,953
Total Current Liabilities	836	530.61	280.91	6,843	2,174
Long-Term Leases	2.01	1.17	1.71	-	-
Long-Term Unearned Revenue	18.93	19.58	18.18	17.58	17.97
Long-Term Deferred Tax Liabilities	61.2	50.68	0.4	0.77	1.24
Total Liabilities	918.14	602.03	301.19	6,861	2,193
Common Stock	0.07	0.06	0.06	0.06	-
Additional Paid-In Capital	-	1,695	1,597	7,160	-
Retained Earnings	-	2,619	1,167	164.8	-
Treasury Stock	-0	-0	-0	-0	-
Comprehensive Income & Other	7,108	48.81	69.72	-6,308	458
Total Common Equity	7,108	4,362	2,833	1,017	458
Minority Interest	11.61	8.91	3.56	-	-
Shareholders' Equity	7,120	4,371	2,837	1,017	458
Total Liabilities & Equity	8,038	4,973	3,138	7,878	2,651
Total Debt	6.71	2.73	2.59	-	-
Net Cash (Debt)	5,872	3,787	2,216	7,263	1,959
Net Cash Growth	55.04%	70.92%	-69.50%	270.86%	137.40%
Net Cash Per Share	5.86	3.85	2.17	7.26	1.96
Filing Date Shares Outstanding	1,009	976	976	900	1,000
Total Common Shares Outstanding	1,009	976	976	900	1,000
Working Capital	5,566	3,604	2,257	598.28	110.21
Book Value Per Share	7.04	4.47	2.90	1.13	0.46
Tangible Book Value	7,102	4,355	2,827	1,009	449.22
Tangible Book Value Per Share	7.04	4.46	2.90	1.12	0.45
Buildings	-	285.49	225.79	184.61	171.54
Machinery	-	131.75	104.62	69.28	59.51
Construction In Progress	-	356.25	244.44	81.58	50.89
Leasehold Improvements	-	9.54	5.56	1.86	1.86

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.